NewAmsterdam Pharma Healthtech
Funding, team structure (meet the founders), partners and clients
Market - Healthtech
Location - Naarden, Netherlands
Description - Founded in 2019, NewAmsterdam Pharma is a clinical stage company focused on
the research and development of transformative therapies for cardio-renal
diseases. Its mission is to improve patient care in populations where
traditional therapies are not tolerated or have been unsuccessful.
Tags - AMG 899 TA CETP Apolipoprotein B ApoB LDL Phase 3
Team
Founder Michael Davidson
Funding
NewAmsterdam Pharma raised $196,000,000 with Morningside Ventures and Kaiser Foundation Hospitals and BVF Partners L, Peter Thiel, Janus Henderson Investors, JVC Investment Partners - 1/14/2021